Pharmaceuticals in the news

Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer treatment deal

Read on: CNBC News

Africa may need its own central medicines agency, says Aspen Pharmacare CEO

Read on: CNN

Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loom

Read on: CNBC News

FDA to undo some layoffs, after cuts to inspections and drug safety

Read on: CBS

Employers are spending more on GLP-1 drugs, but the ROI is already here

Read on: Fast Company

Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs

Read on: CNBC News

Drugs giant GSK 'well positioned' to absorb potential US tariffs

Read on: Independent

US, Japan drugmakers target ALS-causing genes with new therapies

Read on: Nikkei

Merck to invest $1 billion in U.S. drug manufacturing plant

Read on: CBS

Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs

Read on: Wired Magazine

Singapore negotiating for U.S. concessions on pharmaceuticals, chips

Read on: CNBC News

ICICI Lombard to up health biz investments, look at buyouts

Read on: Times of India

Key drug supplier, on the run for over a year, arrested in Hyderabad

Read on: Times of India

Swiss pharmaceuticals company Roche announces $50B investment in U.S. over next 5 years

Read on: The Washington Times

Trump's planned pharmaceutical tariffs would raise costs by $51bn annually, report finds

Read on: Independent

Roche to invest $50 billion in the U.S. as pharma tariff threat lingers

Read on: CNBC News

Trump's tariffs threaten Ireland's pharma fortune

Read on: Financial Times

Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffs

Read on: The Guardian

Healthy Returns: What drugmakers are saying about Trump's looming pharmaceutical tariffs

Read on: CNBC News